Maiko Inagaki

1.0k citations
15 papers · 833 indexed · h-index 13
Topics
NF-κB Signaling Pathways (6 papers)Wnt/β-catenin signaling in development and cancer (5 papers)Hedgehog Signaling Pathway Studies (4 papers)
Partner nations
JapanUnited StatesFrance

In The Last Decade

Maiko Inagaki

15 papers receiving 826 citations

Peers

Maiko Inagaki
Comparison fields: 5 of 84
  • Molecular Biology 546
  • Immunology 233
  • Cancer Research 165
  • Genetics 137
  • Cell Biology 122
Replace Eriks Jankevics with:
Eriks Jankevics Latvia
Yuzo Kadokawa Japan
Takami Takizawa Japan
Sarah E. Moorey United States
Xiaojie Xian Sweden
Wuzhou Yuan China
David G. Ryan United States
Debra J. Gilbert United States
Melody E. Clark United States
Lars Jønson Denmark
Maiko Inagaki relative to Eriks Jankevics Latvia Eriks Jankevics's profile →
Citations per field
00.5×1.5×
Eriks Jankevics · 1×
Citations per year

Countries citing papers authored by Maiko Inagaki

Since Specialization
Citations

This map shows the geographic impact of Maiko Inagaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maiko Inagaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maiko Inagaki more than expected).

Fields of papers citing papers by Maiko Inagaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maiko Inagaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maiko Inagaki. The network helps show where Maiko Inagaki may publish in the future.

Co-authorship network of co-authors of Maiko Inagaki

This figure shows the co-authorship network connecting the top 25 collaborators of Maiko Inagaki. A scholar is included among the top collaborators of Maiko Inagaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maiko Inagaki. Maiko Inagaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 10
2 34
3 63
4 11
5 50
6 34
7 42
8 128
9 14
10 58
11 85
12 100
13 37
14 46
15 121

About Maiko Inagaki

Maiko Inagaki is a scholar working on Cancer Research, Immunology and Allergy and Immunology, having authored 15 papers that have together received 833 indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (6 papers), Wnt/β-catenin signaling in development and cancer (5 papers) and Hedgehog Signaling Pathway Studies (4 papers). The work is most often cited by research in Immunology (233 citations), Cancer Research (165 citations) and Molecular Biology (546 citations). Maiko Inagaki has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Kunihiro Matsumoto, Kenji Irie, Jun Ninomiya‐Tsuji, Yoshimi Takai, Yuji Mishina, Jun Miyoshi, Miki Tanaka, Hiroyoshi Ishizaki, Tobias Schmelzle and Michael N. Hall. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026